Bill117th CongressFiled Jul 21, 2021Health
H.Con.Res. 42
Expressing the sense of Congress that governmental entities should use a portion of the proceeds from litigation against opioid manufacturers and distributors to increase participation in drug take back programs and for the safe disposal of collected, unused medicines.
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (Jul 21, 2021)
This concurrent resolution expresses the sense of Congress that government entities should consider using a portion of proceeds from litigation against opioid manufacturers and distributors for drug take-back programs.
What just happenedJul 22, 2021
Referred to the Subcommittee on Health.
Who’s behind it
Rep. McKinley, David B. [R-WV-1](R-WV)Sponsor
17 cosponsors7 D10 R
17cosponsors1committees4actions8subjects
- Introduced in HouseJul 21, 2021
- Jul 22, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jul 21, 2021IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Jul 21, 2021IntroReferralIntro-H
Introduced in House
- Jul 21, 2021IntroReferral1000
Introduced in House